ReviewExperimental eye research2020

Mitochondrial targeted therapy with elamipretide (MTP-131) as an adjunct to tumor necrosis factor inhibition for traumatic optic neuropathy in the acute setting.

Brian C Tse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.